Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

Yael L. Maxwell

December 12, 2017

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Caitlin E. Cox

November 14, 2017

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

News Daily News

ACC Updates Recommendations for Non-statin Therapy Use for LDL-Cholesterol Lowering in Secondary Prevention

Yael L. Maxwell

September 06, 2017

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

News Daily News

Who Should Get a Statin? Guidelines Don’t Match Up

Michael O'Riordan

April 20, 2017

News Daily News

MR CLEAN: Sustained Benefit of Endovascular Therapy for Acute Ischemic Stroke

Michael O'Riordan

April 05, 2017

News Daily News

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

Todd Neale

April 03, 2017

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Conference News ACC 2017

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Michael O'Riordan

March 10, 2017

News Conference News ISET 2017

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

Caitlin E. Cox

February 13, 2017

News Daily News

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

Yael L. Maxwell

January 31, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

Advertisement

Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

ACC Updates Recommendations for Non-statin Therapy Use for LDL-Cholesterol Lowering in Secondary Prevention

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Who Should Get a Statin? Guidelines Don’t Match Up

MR CLEAN: Sustained Benefit of Endovascular Therapy for Acute Ischemic Stroke

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content